Dr Elena Castro

Go Back

Medical Oncologist

  • Hospital 12 Octubre
  • location Spain

Dr Elena Castro is a Consultant Medical Oncologist at Hospital Universitario 12 de Octubre in Madrid, Spain.  She treats patients with advanced bladder and prostate cancer, most of them within the context of clinical trials. She studied medicine and obtained a PhD from the University of Salamanca, Spain.  After training in medical oncology, she completed a four-year fellowship in Cancer Genetics at the Institute of Cancer Research, UK.   Later, she joined the Spanish National Cancer Research Center as a clinician-scientist.  Her research has focused on addressing the clinical implications of genetic and genomic variants in prostate cancer, receiving several awards for her work. She has also authored numerous articles published in international peer-reviewed journals including some relevant papers on the impact of germline variants in prostate cancer.   

Dr Elena Castro has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Bayer, Janssen, MSD, Novartis, Pfizer, Synlab and Telix. 

Programmes developed by Dr Elena Castro

podcast Podcast

Episode

2

of 3

episode
Oncology 
PARP inhibitors alone or in combination with novel hormonal agents in prostate cancer

Episode 2: Clinical implementation of PARPi and NHA combination therapy for patients with mCRPC – a US and EU perspective

Experts
Dr Neal Shore, Dr Elena Castro
Endorsed by
ZERO
  • download Downloadable
    Resources
  • clock MIN
  • calendar Feb 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast

Episode

1

of 3

episode
Oncology 
PARP inhibitors alone or in combination with novel hormonal agents in prostate cancer

Episode 1: Clinical implementation of PARPi monotherapy for prostate cancer patients – a US and EU perspective

Experts
Dr Neal Shore, Dr Elena Castro
Endorsed by
ZERO
  • download Downloadable
    Resources
  • clock MIN
  • calendar Feb 2023

Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast
Oncology 
El potencial de los inhibidores de PARP en el cáncer de próstata: Lo que las enfermeras deben saber

En el segundo episodio de esta serie de podcasts, Pablo Peinado y la Dra. Elena Castro analizan los inhibidores de PARP, cómo funcionan, revisan datos clave de ensayos, cómo seleccionar PARPi y dónde encajan en la secuencia general de tratamiento.

Experts
Pablo Peinado, Dr Elena Castro
Endorsed by
Urobel VZW | ASBL
  • clock MIN
  • calendar Jan 2022

Educational programme supported by an Independent Educational Grant from AstraZeneca
podcast Podcast

Episode

2

of 3

episode
Oncology 
The potential of PARP inhibitors in prostate cancer: What nurses need to know

Episode 2

Experts
Dr Elena Castro, Pablo Peinado
Endorsed by
Urobel VZW | ASBL
  • download Downloadable
    Resources
  • clock MIN
  • calendar Jan 2022

Educational programme supported by an Independent Educational Grant from AstraZeneca
Oncology 
PARP inhibitors in Prostate Cancer

GU CONNECT has developed a comprehensive resource which is available on ESMO OncologyPRO, providing information on PARP inhibitors in prostate cancer

Experts
Dr Elena Castro, Dr Alexander Wyatt, Prof. Gerhardt Attard, Prof. Steven Joniau
  • clock 30 MIN
  • calendar Dec 2021

Educational programme supported by an Independent Educational Grant from Astrazeneca
Oncology 
GU CONNECT Update from ESMO 2021

GU cancer update by Dr. Elena Castro, Hospital Universitario Virgen de la Victoria, Málaga, Spain.

Experts
Dr Elena Castro
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Oct 2021

Educational programme supported by an Independent Educational Grant from Bayer